Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain.

Deza G, Notario J, Ferran M, Beltrán E, Almirall M, Alcalá R, Ruiz-Carrascosa JC, Sánchez R, Pérez S, García-Vivar ML, Galíndez E, Mora M, Rodríguez J, Gallardo F.

Rheumatol Int. 2018 Aug 24. doi: 10.1007/s00296-018-4144-8. [Epub ahead of print]

PMID:
30143818
2.

Current Status of Multidisciplinary Care in Psoriatic Arthritis in Spain: NEXUS 2.0 Project.

Queiro R, Coto P, Joven B, Rivera R, Navío Marco T, de la Cueva P, Alvarez Vega JL, Narváez Moreno B, Rodriguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Rodríguez J, Notario J, Pujol Busquets M, García Font M, Galindez E, Pérez Barrio S, Urruticoechea-Arana A, Hergueta M, López Montilla MD, Vélez García-Nieto A, Maceiras F, Rodríguez Pazos L, Rubio Romero E, Rodríguez Fernandez Freire L, Luelmo J, Gratacós J.

Reumatol Clin. 2018 Feb 26. pii: S1699-258X(18)30030-5. doi: 10.1016/j.reuma.2018.01.010. [Epub ahead of print] English, Spanish.

3.

Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain.

Gratacós J, Luelmo J, Rodríguez J, Notario J, Marco TN, de la Cueva P, Busquets MP, Font MG, Joven B, Rivera R, Vega JLA, Álvarez AJC, Parera RS, Carrascosa JCR, Martínez FJR, Sánchez JP, Olmos CF, Pujol C, Galindez E, Barrio SP, Arana AU, Hergueta M, Coto P, Queiro R.

Rheumatol Int. 2018 Jun;38(6):1115-1124. doi: 10.1007/s00296-018-3986-4. Epub 2018 Feb 7.

PMID:
29417210
4.

Moderate Psoriasis: A Proposed Definition.

Llamas-Velasco M, de la Cueva P, Notario J, Martínez-Pilar L, Martorell A, Moreno-Ramírez D.

Actas Dermosifiliogr. 2017 Dec;108(10):911-917. doi: 10.1016/j.ad.2017.07.002. Epub 2017 Aug 17. Review. English, Spanish.

PMID:
28823420
5.

Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service.

Puig L, Notario J, Jiménez-Morales A, Moreno-Ramírez D, López-Ferrer A, Gozalbo I, Prades M, Lizán L, Blanch C.

J Dermatolog Treat. 2017 Nov;28(7):623-630. doi: 10.1080/09546634.2017.1364687. Epub 2017 Oct 5.

PMID:
28784002
6.

Adult-onset Still's disease with atypical cutaneous manifestations.

Narváez Garcia FJ, Pascual M, López de Recalde M, Juarez P, Morales-Ivorra I, Notario J, Jucglà A, Nolla JM.

Medicine (Baltimore). 2017 Mar;96(11):e6318. doi: 10.1097/MD.0000000000006318.

7.

Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice.

Almirall M, Rodriguez J, Mateo L, Carrascosa JM, Notario J, Gallardo F.

Clin Rheumatol. 2017 Feb;36(2):439-443. doi: 10.1007/s10067-016-3464-x. Epub 2016 Nov 5.

PMID:
27817126
8.

Perception of psoriasis treatment in the outpatient setting: survey of patients and their prescribing physicians.

Carrascosa JM, de la Cueva P, Herranz P, Labandeira J, Notario J.

J Dermatolog Treat. 2017 May;28(3):188-199. doi: 10.1080/09546634.2016.1230174. Epub 2016 Sep 19.

PMID:
27569650
9.

Multidisciplinary Care Models for Patients With Psoriatic Arthritis.

Queiro R, Coto P, Rodríguez J, Notario J, Navío Marco T, de la Cueva P, Pujol Busquets M, García Font M, Joven B, Rivera R, Alvarez Vega JL, Chaves Álvarez AJ, Sánchez Parera R, Ruiz Carrascosa JC, Rodríguez Martínez FJ, Pardo Sánchez J, Feced Olmos C, Pujol C, Galindez E, Pérez Barrio S, Urruticoechea Arana A, Hergueta M, Luelmo J, Gratacós J.

Reumatol Clin. 2017 Mar - Apr;13(2):85-90. doi: 10.1016/j.reuma.2016.03.005. Epub 2016 Apr 8. English, Spanish.

10.

ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice.

Vilarrasa E, Notario J, Bordas X, López-Ferrer A, Gich IJ, Puig L.

J Am Acad Dermatol. 2016 Jun;74(6):1066-72. doi: 10.1016/j.jaad.2016.01.037. Epub 2016 Mar 19.

PMID:
27004803
11.

Physicians' opinions following pharmacogenetic testing for psychotropic medication.

Walden LM, Brandl EJ, Changasi A, Sturgess JE, Soibel A, Notario JF, Cheema S, Braganza N, Marshe VS, Freeman N, Tiwari AK, Kennedy JL, Müller DJ.

Psychiatry Res. 2015 Oct 30;229(3):913-8. doi: 10.1016/j.psychres.2015.07.032. Epub 2015 Aug 7.

PMID:
26298505
12.

Drug survival in biologic therapy. Do we know what it means? Can we calculate it?

Carrascosa JM, Notario J.

Actas Dermosifiliogr. 2014 Oct;105(8):729-33. doi: 10.1016/j.ad.2014.04.004. Epub 2014 Jun 2. English, Spanish. No abstract available.

PMID:
24882614
13.

Use of biological treatments in patients with hidradenitis suppurativa.

Martin-Ezquerra G, Masferrer E, Masferrer-Niubò M, Ferran M, Sánchez-Regaña M, Collgros H, Bordas X, Notario J, Alsina M, Gil I, Izquierdo N, Aparicio G, Mollet J, Garcia-Patos V, Pujol RM.

J Eur Acad Dermatol Venereol. 2015 Jan;29(1):56-60. doi: 10.1111/jdv.12438. Epub 2014 Mar 13.

PMID:
24629001
14.

Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

Puig L, Carrascosa JM, Carretero G, de la Cueva P, Lafuente-Urrez RF, Belinchón I, Sánchez-Regaña M, García-Bustínduy M, Ribera M, Alsina M, Ferrándiz C, Fonseca E, García-Patos V, Herrera E, López-Estebaranz JL, Marrón SE, Moreno JC, Notario J, Rivera R, Rodriguez-Cerdeira C, Romero A, Ruiz-Villaverde R, Taberner R, Vidal D; Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

Actas Dermosifiliogr. 2013 Oct;104(8):694-709. doi: 10.1016/j.adengl.2013.04.013. Epub 2013 Sep 7.

PMID:
24018211
15.

Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

Carretero G, Ribera M, Belinchón I, Carrascosa JM, Puig L, Ferrandiz C, Dehesa L, Vidal D, Peral F, Jorquera E, González-Quesada A, Muñoz C, Notario J, Vanaclocha F, Moreno JC; Psoriasis Group of the AEDV.

Actas Dermosifiliogr. 2013 Sep;104(7):598-616. doi: 10.1016/j.adengl.2013.01.001. Epub 2013 Jul 23.

PMID:
23891453
16.

Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection.

Marcoval J, Notario J, Martín C, Gómez S.

Actas Dermosifiliogr. 2014 Mar;105(2):211-2. doi: 10.1016/j.ad.2013.01.008. Epub 2013 Apr 25. English, Spanish. No abstract available.

PMID:
23623282
17.

Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid.

Rubio L, Alonso C, López O, Rodríguez G, Coderch L, Notario J, de la Maza A, Parra JL.

Int J Dermatol. 2011 Jul;50(7):881-9. doi: 10.1111/j.1365-4632.2010.04819.x.

PMID:
21699529
18.

[Pigmentation of the fungiform papillae of the tongue: a report of 2 cases].

Marcoval J, Notario J, Martín-Sala S, Figueras I.

Actas Dermosifiliogr. 2011 Nov;102(9):739-40. doi: 10.1016/j.ad.2011.01.012. Epub 2011 Jun 8. Spanish. No abstract available.

PMID:
21641566
19.

[Guidelines on the use of methotrexate in psoriasis].

Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC; Grupo de Psoriasis de la AEDV.

Actas Dermosifiliogr. 2010 Sep;101(7):600-13. Spanish.

PMID:
20858386
20.

Guidelines on the Use of Methotrexate in Psoriasis.

Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC; Grupo de Psoriasis de la AEDV.

Actas Dermosifiliogr. 2010 Sep;101(7):600-613. doi: 10.1016/j.ad.2010.04.002. Epub 2010 Jul 31. English, Spanish.

PMID:
28709542

Supplemental Content

Loading ...
Support Center